CLSI MM03A2

Molecular Diagnostic Methods for Infectious Diseases; Approved Guideline, MM03-A2

Clinical and Laboratory Standards Institute, 02/17/2006

Publisher: CLSI

File Format: PDF

$142.00$285.63

Description

Published:17/02/2006

Pages:88

This guideline addresses topics relating to clinical applications, amplified and nonamplified nucleic acid methods, selection and qualification of nucleic acid sequences, establishment and evaluation of test performance characteristics, inhibitors, and interfering substances, controlling false-positive reactions, reporting and interpretation of results, quality assurance, regulatory issues, and recommendations for manfactuers and clinical laboratories.

More CLSI standard pdf

CLSI M24S

Performance Standards for Susceptibility Testing of Mycobacteria, Nocardia spp., and Other Aerobic Actinomycetes, 2nd Edition, M24SEd2E

$40.00 $80.00

CLSI EP26-Ed2-IG

User Evaluation of Acceptability of a Reagent Lot Change Implementation Guide, EP26-Ed2-IG

$25.00 $50.00

CLSI M57S

Epidemiological Cutoff Values for Antifungal Susceptibility Testing, 4th Edition, M57SEd4

$40.00 $80.00

CLSI M27M44S

Performance Standards for Antifungal Susceptibility Testing of Yeasts, 3rd Edition, M27M44S

$40.00 $80.00